Key Elements of a Documented Asthma Action Plan

Patient Identification and Baseline Assessment

Green Zone (80‑100 % of Personal Best PEF) – “Doing Well”

Yellow Zone (50‑79 % of Personal Best PEF) – “Getting Worse”

Red Zone (< 50 % of Personal Best PEF) – “Medical Alert”

Trigger Identification and Avoidance

Inhaler Technique Documentation

Follow‑up and Review

Common Documentation Pitfalls to Avoid

Integration with Patient Education

Asthma Action Plan Guidelines

Essential Components of the Action Plan

• The American Academy of Allergy, Asthma, and Immunology recommends that every patient with asthma should receive a written asthma action plan that includes specific instructions for daily management and clear criteria for recognizing and responding to worsening asthma, with this being particularly essential for patients with moderate-to-severe persistent asthma, history of severe exacerbations, or poorly controlled disease 4, 5
• The action plan should document the patient's baseline status and daily medications, including all long-term controller medications with specific doses and frequency, such as inhaled corticosteroids taken daily to prevent inflammation 4, 6
• The American Thoracic Society recommends that quick-relief medications, such as short-acting beta-agonists, should be used ≤2 days per week for symptom relief 4, 5
• The action plan should specify that patients should use their quick-relief medication immediately if they experience severe breathlessness, and call 911 or go directly to the emergency department if symptoms persist 7
• The American College of Allergy, Asthma, and Immunology recommends that patients with asthma should have a personal best peak expiratory flow (PEF) value if using peak flow monitoring, and that this value should be used to determine the severity of asthma exacerbations 4

Tailoring the Plan to Individual Patient Factors

• The National Asthma Education and Prevention Program recommends that the action plan should be tailored to individual patient factors, including health literacy level, cultural beliefs and practices, and history of severe exacerbations or hospitalizations 4, 8
• The action plan should include specific allergen avoidance measures based on skin or in vitro testing results for patients with persistent asthma 4, 8

Implementation and Follow-up

• The American Academy of Allergy, Asthma, and Immunology recommends that the action plan should be developed collaboratively with the patient, and that patients should be educated on the proper use of their medications and how to recognize and respond to worsening asthma 4
• The action plan should be reviewed and updated at follow-up visits as asthma control changes, and patients should be instructed on how to adjust their medication regimen based on their symptoms and PEF 5, 8
• The American Thoracic Society recommends that patients with asthma should be scheduled for regular follow-up visits, every 1-6 weeks while gaining control, and every 1-6 months once control is maintained, depending on treatment step 5, 8